Novare Capital Management LLC lowered its position in UnitedHealth Group Inc. (NYSE:UNH) by 0.3% during the second quarter, Holdings Channel reports. The institutional investor owned 37,296 shares of the healthcare conglomerate’s stock after selling 105 shares during the period. UnitedHealth Group accounts for 1.4% of Novare Capital Management LLC’s portfolio, making the stock its 23rd largest position. Novare Capital Management LLC’s holdings in UnitedHealth Group were worth $5,266,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MCF Advisors LLC increased its stake in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock valued at $123,000 after buying an additional 726 shares during the period. Parkside Financial Bank & Trust increased its stake in shares of UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 238 shares during the period. Feltz Wealth PLAN Inc. bought a new stake in shares of UnitedHealth Group during the second quarter valued at about $143,000. Benjamin F. Edwards & Company Inc. increased its stake in shares of UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock valued at $153,000 after buying an additional 518 shares during the period. Finally, Evanson Asset Management LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at about $201,000. 85.78% of the stock is currently owned by institutional investors.

UnitedHealth Group Inc. (NYSE:UNH) traded up 0.4960% during trading on Wednesday, reaching $138.1519. The company’s stock had a trading volume of 1,396,039 shares. The company’s 50 day moving average price is $139.00 and its 200 day moving average price is $135.11. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $144.48. The company has a market cap of $131.57 billion, a P/E ratio of 21.6200 and a beta of 0.57.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, beating the consensus estimate of $1.89 by $0.07. The company earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. On average, equities analysts anticipate that UnitedHealth Group Inc. will post $7.92 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were given a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a dividend yield of 1.82%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s payout ratio is 39.12%.

Several research firms recently commented on UNH. Cowen and Company set a $150.00 target price on UnitedHealth Group and gave the company a “buy” rating in a research report on Tuesday, September 6th. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $161.00 target price (up from $145.00) on shares of UnitedHealth Group in a research report on Friday, July 22nd. Leerink Swann restated an “outperform” rating and issued a $165.00 target price (up from $155.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. Wedbush restated an “outperform” rating and issued a $165.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 19th. Finally, Credit Suisse Group AG restated a “buy” rating and issued a $155.00 target price (up from $148.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. One research analyst has rated the stock with a hold rating, twenty-three have given a buy rating and one has given a strong buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $154.96.

In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the sale, the director now owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.65% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).

Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.